Ignite Creation Date:
2024-05-05 @ 10:55 PM
Last Modification Date:
2024-10-26 @ 10:25 AM
Study NCT ID:
NCT01212263
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2010-09-29
Brief Title:
Clomiphene Citrate CC Co-treatment With HP Urinary FSH vs HP Urinary FSH in CC-resistant PCOS
Sponsor:
Mansoura Integrated Fertility Center
Organization:
Mansoura Integrated Fertility Center
Study Overview
Official Title:
Clomiphene Citrate Co-treatment With Low Dose HP Urinary FSH vs HP Urinary FSH Step-up Protocol for Clomiphene-citrate Resistant PCOS Anovulatory Infertility Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To test whether adding small doses of HP urinary FSH to standard regimen of clomiphene citrate in clomiphene resistant PCOS well yield better results in terms of better ovulation ratelower follicle number less consumption of HP urinary FSHlower treatment cost better pregnancy rate lower multiple pregnancy rates compared with the exclusive use of HP urinary FSH in these cases
Detailed Description:
To test whether CC co- treatment with chronic low dose HP uFSH vs chronic low dose HP uFSH in CC resistant PCOS will yield better results in terms of ovulation rate lower follicle numberlower HP uFSH dose better outcome in terms of pregnancy rates better cost-effectiveness ratio lower multiple pregnancy rateslower cycle cancellation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None